leuprolide acetate injection solution — CareFirst (Caremark)
Inhibition of premature luteinizing hormone (LH) surges in members undergoing ovulation induction or assisted reproductive technology (ART)
Initial criteria
- Used for inhibition of premature LH surges in members undergoing ovulation induction or ART
Approval duration
12 months